European Alzheimer's Disease Study 2020: Pipeline, Epidemiology, Market Valuations, Drug Sales & Shares, Competition (2016-2024)

DUBLIN, July 3, 2020 /PRNewswire/ -- The "Europe Alzheimer's Disease Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive insights into the Alzheimer's Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Alzheimer's Disease market size and drug sales. It also provides insights into Alzheimer's Disease epidemiology and late stage pipeline.

This research covers the following: Alzheimer's Disease treatment options, Alzheimer's Disease late stage clinical trials pipeline, Alzheimer's Disease prevalence by countries, Alzheimer's Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope

• Countries: Germany, France, Italy, Spain, UK, Europe
• Alzheimer's Disease pipeline: Find out drugs in clinical trials for the treatment of Alzheimer's Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
• Alzheimer's Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Alzheimer's Disease by countries
• Alzheimer's Disease drugs: Identify key drugs marketed and prescribed for Alzheimer's Disease in the US, including trade name, molecule name, and company
• Alzheimer's Disease drugs sales: Find out the sales value for Alzheimer's Disease drugs by countries
• Alzheimer's Disease market valuations: Find out the market size for Alzheimer's Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
• Alzheimer's Disease drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research

• Evaluate commercial market opportunities for Alzheimer's Disease drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in the Alzheimer's Disease market
• Develop in-depth knowledge of competition and markets
• Analyze Alzheimer's Disease drug sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track Market Events and Trends and analyze key events in the Alzheimer's Disease market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered

1. Alzheimer's Disease Treatment Options

2. Alzheimer's Disease Pipeline Insights
2.1. Alzheimer's Disease Phase 3 Clinical Trials
2.2. Alzheimer's Disease Phase 2 Clinical Trials
2.3. Alzheimer's Disease Phase 1 Clinical Trials

3. Alzheimer's Disease Epidemiology Analysis by Countries

4. Germany Alzheimer's Disease Market Insights
4.1. Marketed Drugs for Alzheimer's Disease in Germany
4.2. Germany Alzheimer's Disease Market Size & Forecast
4.3. Germany Alzheimer's Disease Drugs Sales Forecast
4.4. Germany Alzheimer's Disease Market Share Analysis

5. France Alzheimer's Disease Market Insights
5.1. Marketed Drugs for Alzheimer's Disease in France
5.2. France Alzheimer's Disease Market Size & Forecast
5.3. France Alzheimer's Disease Product Sales Forecast
5.4. France Alzheimer's Disease Market Share Analysis

6. Italy Alzheimer's Disease Market Insights
6.1. Marketed Drugs for Alzheimer's Disease in Italy
6.2. Italy Alzheimer's Disease Market Size & Forecast
6.3. Italy Alzheimer's Disease Product Sales Forecast
6.4. Italy Alzheimer's Disease Market Share Analysis

7. Spain Alzheimer's Disease Market Insights
7.1. Marketed Drugs for Alzheimer's Disease in Spain
7.2. Spain Alzheimer's Disease Market Size & Forecast
7.3. Spain Alzheimer's Disease Product Sales Forecast
7.4. Spain Alzheimer's Disease Market Share Analysis

8. UK Alzheimer's Disease Market Insights
8.1. Marketed Drugs for Alzheimer's Disease in UK
8.2. UK Alzheimer's Disease Market Size & Forecast
8.3. UK Alzheimer's Disease Product Sales Forecast
8.4. UK Alzheimer's Disease Market Share Analysis

9. Europe Alzheimer's Disease Market Insights
9.1. Europe Alzheimer's Disease Market Size & Forecast
9.2. Europe Alzheimer's Disease Product Sales Forecast
9.3. Europe Alzheimer's Disease Market Share Analysis

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/50o8f8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/european-alzheimers-disease-study-2020-pipeline-epidemiology-market-valuations-drug-sales--shares-competition-2016-2024-301088048.html

SOURCE Research and Markets